Genetic control of glycolipid expression

Area of Science:

• Biochemistry and Genetics
• Glycosphingolipid Metabolism
• Mammalian Erythrocyte and Liver Glycobiology

Background:

• Sialic acids are critical components of glycosphingolipids, influencing cell recognition and signaling.
• Polymorphic variations in sialic acid species, such as N-glycolylneuraminic acid (NeuGc) and N-acetylneuraminic acid (NeuAc), exist across species and individuals.
• Gangliosides, a major class of sialic acid-containing glycosphingolipids, play diverse biological roles in the liver and cell membranes.

Purpose of the Study:

• To investigate the genetic basis of polymorphic variations in sialosyllactosylceramide in dog erythrocytes.
• To analyze genetic control over major liver ganglioside expression in inbred mouse strains.
• To identify specific enzyme deficiencies and gene linkages associated with distinct ganglioside profiles.

Main Methods:

• Analysis of glycolipid composition in erythrocytes from a Shiba-Inu dog family.
• Biochemical and genetic analysis of liver gangliosides in various inbred mouse strains.
• Enzyme activity assays (N-acetylgalactosaminyltransferase, galactosyltransferase) and linkage analysis with the H-2 complex.

Main Results:

• In Shiba-Inu dogs, N-glycolylneuraminic acid-containing sialosyllactosylceramide expression is an autosomal dominant trait over N-acetylneuraminic acid.
• Inbred mouse strains exhibited distinct liver ganglioside profiles, classified into three groups based on the presence of specific gangliosides (II3NeuGc-LacCer, II3NeuGc-GgOse3Cer, II3NeuGc-GgOse4Cer, II3NeuGc,IV3NeuGc-GgOse4Cer).
• Genetic analysis identified recessive autosomal defective genes responsible for deficiencies in N-acetylgalactosaminyltransferase and galactosyltransferase activities, with the latter linked to the H-2 complex on chromosome 17.

Conclusions:

• The expression of sialosyllactosylceramide in dogs is genetically controlled by an autosomal dominant trait.
• Mammalian ganglioside biosynthesis is regulated by specific enzyme activities, with genetic defects leading to distinct metabolic phenotypes.
• The gene controlling the expression of II3NeuGc-GgOse4Cer in mice is linked to the H-2 complex, suggesting a role for immune system-related genes in glycosphingolipid metabolism.